about
Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?PPARG: Gene Expression Regulation and Next-Generation Sequencing for Unsolved Issues.Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases.Genetic characterization of Greek population isolates reveals strong genetic drift at missense and trait-associated variantsPeroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.Peroxisome proliferator-activated receptor gamma rs1801282 C>G polymorphism is associated with polycystic ovary syndrome susceptibility: a meta-analysis involving 7,069 subjects.Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?Impact of the Pro12Ala polymorphism of the PPAR-Gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients.Polymorphisms FTO rs9939609, PPARG rs1801282 and ADIPOQ rs4632532 and rs182052 but not lifestyle are associated with obesity related-traits in Mexican children.Regulation of Translational Efficiency by Disparate 5' UTRs of PPARgamma Splice Variants.Nutrigenomic Functions of PPARs in Obesogenic Environments.Phytochemicals targeting genes relevant for type 2 diabetes.Obesity-related genetic polymorphisms and adiposity indices in a young Italian population.Polymorphisms in adiposity-related genes are associated with age at menarche and menopause in breast cancer patients and healthy women.Is the rs1801282 (G/C) Polymorphism of PPAR - Gamma Gene Associated with T2DM in Iraqi People?Association of PPAR-γ gene polymorphisms with obesity and obesity-associated phenotypes in North Indian population.Probing the role of PPARγ in the regulation of late-onset Alzheimer's disease-associated genes.Relationship of , , and polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population
P2860
Q30388214-EA70D0DB-A2ED-46F3-8BE0-58603CEEB3C1Q34143718-254C83A0-AC43-4BDC-B25F-4A629BAF8D8AQ34406470-A84245BA-74A8-4804-849F-3830D792C485Q34565337-EF1F6467-0EFF-48B4-B90B-0BE62538AD6BQ36182663-C508C172-0077-419A-BDD2-CD8E8276145CQ36411517-BC5F9630-B515-40B2-9E59-7122095FFDD4Q36619149-7E2BC607-5675-4D9F-A68A-CD4067D0EC4EQ37105099-985F1800-90A3-4B03-9F93-EEFD93DF19B8Q37397885-9085F727-08ED-49D9-93F9-6045C2FE3710Q37450494-10762D5F-628E-4C58-8BB4-3748C9D7C88CQ37474090-494E1E50-CFA6-41CE-B4F9-C04A9C2FA8E8Q37500797-2FC399B6-454A-42BE-B275-5820F9F3C0BDQ38112779-AB0F1967-F571-483E-AFC7-50D2D0BB96A3Q40379647-B41A95AE-CC71-45C5-8DA7-78114BF164FBQ53098888-4A0E0496-D747-4B83-B33B-13C8BBC19C24Q53833058-C188EECB-23EF-4B34-B139-895192666DC2Q54319581-7FAEA92F-7AC7-4A4E-8A18-D96EE53962E1Q55030378-FEC23669-F788-464D-8A48-BD8C70BE713DQ58795640-A9735640-200F-4A4C-AB64-483969218F45
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPARγ2 polymorphism and human health.
@en
PPARγ2 polymorphism and human health.
@nl
type
label
PPARγ2 polymorphism and human health.
@en
PPARγ2 polymorphism and human health.
@nl
prefLabel
PPARγ2 polymorphism and human health.
@en
PPARγ2 polymorphism and human health.
@nl
P2860
P356
P1433
P1476
PPARγ2 polymorphism and human health.
@en
P2093
P2860
P304
P356
10.1155/2009/849538
P577
2009-04-16T00:00:00Z